Graphene oxide not an ingredient in magnetic antibiotic capsule

A viral video circulating online falsely claimed that a commonly prescribed antibiotic capsule contains graphene oxide, a material known for its unique electrical and mechanical properties. The clip showed a person holding a magnet near a flucloxacillin tablet, with the black end of the capsule seemingly being drawn toward the magnet. The video’s caption warned viewers that the medication contained "GRAPHENE OXICIDE Metal Conductors," suggesting a potential health risk linked to the presence of this substance. The video sparked concern among some viewers who questioned why their medications might contain such materials. Flucloxacillin is a widely used antibiotic, typically prescribed to treat bacterial infections. However, according to the manufacturer, Medreich, graphene oxide is not an ingredient in the 500mg flucloxacillin capsules. The company confirmed that the capsule does not include graphene oxide in its formulation and emphasized that the material is not listed in the drug’s Summary of Product Characteristics, a legal document outlining the medicine’s properties and usage guidelines. Further clarification came from Medreich regarding the composition of the capsule. The firm stated that the capsule shell is made of gelatine and is colored using iron oxides. Specifically, the cap of the capsule contains iron oxide black as a colorant, while the body includes iron oxide red and yellow. Titanium dioxide is also present as an opacifier, helping to achieve the capsule’s light or white appearance. These components explain the observed magnetic attraction in the video, as iron oxides are inherently magnetic. The phenomenon described in the video has been previously debunked in relation to another antibiotic, amoxicillin. In that case, the magnetic behavior was similarly attributed to the presence of iron oxide used as a coloring agent rather than any potentially harmful additive. Medreich reiterated that the magnetization effect seen in the flucloxacillin capsules is due to the minimal amount of iron oxide black in the cap, approximately 3.37 mg per capsule. This quantity is far below the level considered dangerous for human consumption, even when accounting for the maximum recommended daily dose of four tablets. Despite the confirmation from the manufacturer, the video continues to circulate online, raising questions about the accuracy of information shared through social media platforms. Misinformation about medications can lead individuals to make unsafe choices regarding their health, including altering dosages or discontinuing necessary treatments based on unfounded fears. Health professionals and regulatory bodies emphasize the importance of verifying medical information through credible sources before acting on it. The incident highlights the broader issue of how easily scientific misunderstandings can spread through digital channels. While the materials used in pharmaceutical products are subject to rigorous testing and regulation, public perception can sometimes be influenced by misleading visuals or incomplete explanations. In this case, the magnetic property of the capsule is entirely attributable to standard coloring agents, not to any novel or hazardous substances. Medical experts caution against drawing conclusions about a product’s safety based solely on visual demonstrations or anecdotal claims. They recommend consulting healthcare providers or pharmacists for accurate information about prescription medications. Additionally, they encourage users to verify the authenticity of online content, especially when it pertains to health-related topics. As more people turn to the internet for health advice, ensuring access to reliable and factual information becomes increasingly critical.